Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed vs Gemcitabine with Cisplatin in Advanced Non-squamous NSCLC
NCT01005680Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Nov 2009
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pemetrexed in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Eli Lilly and Company. Started Nov 2009; status: completed.
02
Drugs
pemetrexed
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT01005680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01005680.